Menu
Recruiting NCT07366164

Hemodynamic Optimization Using an Artificial Intelligenze System

No phase Interventional Hemodynamic (MAP) Stability Fluid Management

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: assisted fluid therapy.
Who it may be relevant to
Registry conditions: Hemodynamic (MAP) Stability, Fluid Management. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Assisted Fluid Management For High-Risk Patients During Colorectal Surgery: A Randomised Controlled Clinical Trial

Overview

This study will investigate the impact of using an automated fluid management system on intraoperative fluid therapy in patients undergoing colorectal surgery. The aim is to evaluate whether automated guidance can optimize hemodynamic stability and reduce the incidence of arterial hypotension,

Interventions

  • Device assisted fluid therapy
    for this intervention, fluids will be administered using an assisted fluid device

Primary outcome measures

  • amounts of fluids [Time frame: at the end of surgery]

Eligibility criteria

Inclusion criteria

\- patients >18 years old and ASA 3 scheduled for laparoscopic colorectal surgery

Exclusion criteria

  • Refusal of consent
  • Body Mass Index > 35 kg/m2
  • urgent cases
  • pregnancy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Other

Study locations

Italy · 1 center
  • Fondazione Policlinico Universitario Policlinico Gemelli — Roma

Identifiers

NCT: NCT07366164 · 7755

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗